Intellectual Property

  • July 27, 2026

    Stewart Leaving USPTO This Week For Private Sector Job

    Deputy U.S. Patent and Trademark Office Director Coke Morgan Stewart will leave the office this week to return to the private sector, she told the USPTO executive staff Monday in a message obtained by Law360.

  • July 27, 2026

    End Defamation Claim Against Baker Botts Atty, Court Advised

    A Florida federal magistrate judge has recommended that a defamation claim against a Baker Botts LLP patent attorney be tossed, saying an inventor hasn't shown that the lawyer's comments to a reporter at issue in the case were defamatory.

  • July 27, 2026

    Arnold & Porter Hires King & Spalding ITC-Focused Atty

    Arnold & Porter Kaye Scholer LLP has hired a King & Spalding LLP partner in Washington, D.C., who will continue his intellectual property work focused on the cross-border aspects of technology and life sciences disputes, the firm announced Monday.

  • July 24, 2026

    Phillips 66 Inks Deal To End Patent Case Revived By Fed. Circ.

    Phillips 66 has settled allegations it infringed Magema Technology's oil refinery patents, reaching a deal nearly a year after the Federal Circuit held that ordered a new trial in the yearslong battle.

  • July 24, 2026

    IP Cases In The Spotlight As ITC Adds 5 New Commissioners

    The Senate's confirmation of five new commissioners at the International Trade Commission, including two who were staffers on the intellectual property committees in Congress, could lead to a greater focus on IP cases at the commission and efforts to speed them up, attorneys say.

  • July 24, 2026

    Big Fish Can't Pursue Apple Store Takedown, Dev Says

    An Armenian game developer accused of withholding source code belonging to Big Fish Games urged a Washington federal judge Friday to block the company's attempt to have games removed from the Apple Store.

  • July 24, 2026

    Full Fed. Circ. Urged To Reconsider Pfizer's Paxlovid IP Win

    Enanta Pharmaceuticals is asking the Federal Circuit to rethink its June refusal to revive a patent it had asserted against Pfizer over its COVID-19 treatment Paxlovid, saying the court acted beyond its authority.

  • July 24, 2026

    Daily Beast Sued Over Image Of CEO In Viral Coldplay Incident

    A photographer sued the Daily Beast in New York federal court on Friday for using his image of Andy Byron, the former CEO of software company Astronomer who was caught in a viral "kiss cam" incident at a Coldplay concert.

  • July 24, 2026

    Finch Therapeutics Can Seek Ch. 11 Plan Votes

    A Delaware bankruptcy judge on Friday conditionally approved the disclosure statement for microbiome treatment developer Finch Therapeutics' Chapter 11 plan, allowing it to solicit creditor votes.

  • July 24, 2026

    Yale Age Test, Allergy Death, Wine Royalties: A Midyear Report

    In the second half of 2026, Connecticut courts are being called upon to decide closely watched issues such as whether the state's largest hospital group violated federal disability and age discrimination laws when requiring providers over age 70 to undergo mandatory cognitive tests.

  • July 24, 2026

    NCAA Urges Judge To Not Let Athletes 'Rewrite' NIL Deal

    The NCAA has opposed an effort to relax the oversight of college athletes' third-party branding deals, telling a California federal judge that the players are looking to "rewrite" a historic antitrust settlement. 

  • July 24, 2026

    Fed. Circ. Backs Invalidating More PTAB Railcar Patent Claims

    The Federal Circuit on Friday backed another Patent Trial and Appeal Board decision that claims in an Amsted Rail Co. Inc. patent on monitoring trains were invalid, less than two months after affirming similar board decisions on two other patents.

  • July 24, 2026

    Novo Asks NJ Judge To Stop Lilly's 'Deceptive' GLP-1 Ads

    Novo Nordisk Inc. asked a New Jersey federal court Friday to block rival Eli Lilly & Co. from running ads allegedly comparing their respective GLP-1 drugs using "outdated" clinical trials and "false superiority messages," arguing the ads are damaging its reputation and misleading consumers.

  • July 24, 2026

    Spotify 'Slow-Rolled' Discovery In Audiobook Case, Court Told

    A nonprofit royalties distribution group said Spotify has "slow-rolled" discovery in a case challenging its new method for calculating artist royalties and asked a Manhattan federal judge to order the streaming giant to produce key documents.

  • July 24, 2026

    Vicor Rival Alleges Trade Secret Misuse In WDTX Suit

    Semiconductor company Delta Electronics accused competitor Vicor Corp. of disclosing its confidential trade secrets as part of a campaign of aggressively pursuing patent allegations against rivals in order to get licensing revenue.

  • July 24, 2026

    5 TM Cases & 1 Strategy To Watch In 2026's Second Half

    The U.S. Supreme Court will weigh a trademark dispute that asks whether juries or judges should decide if a mark is inherently strong, while courts will continue testing the impact of the justices' Jack Daniel's decision over a key test in trademark infringement cases. Here are Law360's picks for trademark cases to watch for the rest of the year.

  • July 24, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen financial advice firm Smith Square Partners sue ailing social housing company Home REIT, Pogust Goodhead hit with a contract claim by one of its investors, and Entain faced with its latest claim in expanding litigation linked to alleged bribery at its former Turkish business. Here, Law360 looks at these and other new claims in the U.K.

  • July 24, 2026

    Sensodyne, Aquafresh Makers Sue Over Rival's 'Sensio' TMs

    The companies behind Sensodyne and Aquafresh have sued a beauty and personal care retailer, alleging its "Sensio" toothpaste range and "Triple Protect" oral care products could cause consumers to confuse them with their best-selling brands.

  • July 23, 2026

    Patent Atty Sues USPTO Over 'Flawed' Disciplinary Procedure

    An Ohio patent lawyer Thursday accused the U.S. Patent and Trademark Office of using an unlawful "pay for play" system for its disciplinary proceedings against attorneys, claiming the disciplinary proceedings are "inherently biased" and rigged against him and others facing discipline.

  • July 23, 2026

    Samsung Seeks $1B Bond If Pictiva's Injunction Bid Granted

    Three Samsung entities urged a Texas federal judge on Wednesday to reject Pictiva's motion for a preliminary injunction to ban them from selling high-end QD-OLED TVs while a suit over Pictiva's patents plays out, but said if such extraordinary relief is granted, it should come with a $1 billion bond.

  • July 23, 2026

    Google Must Face Ex-NPR Host's AI Voice Suit In State Court

    A California federal judge ruled Thursday that former NPR "Morning Edition" co-host David Greene's claims that Google misappropriated his voice in an artificial intelligence podcasting product could proceed in state court, rejecting Google's contention that his claims arose under the Copyright Act and thus belong in federal court.

  • July 23, 2026

    Lenovo Wants 'Bad Faith' Infringement Claims Shut Down

    Lenovo on Wednesday asked a North Carolina federal judge to step in and halt a "coordinated campaign of bad faith patent assertions" from Longhorn IP, claiming that the state's Abusive Patent Assertions Act was designed to protect Lenovo from "precisely this kind of conduct."

  • July 23, 2026

    PTAB Revives Ioengine Data Patent In Roku Reexam Case

    The Patent Trial and Appeal Board has reversed an examiner's decision to strike claims in an Ioengine LLC data processing patent that was challenged by Roku, faulting the examiner's reading and application of relevant pieces of prior art.

  • July 23, 2026

    8th Circ. Says Vendor Didn't Show Major Harm In Bank IP Fight

    The Eighth Circuit on Thursday upheld a Missouri federal judge's refusal to block Commerce Bank from using software that a vendor alleges was developed with its trade secrets, ruling the vendor failed to show it was likely to suffer harm that could not be remedied later.

  • July 23, 2026

    Firm Must Share Sanctions In Door IP Suit, Fed. Circ. Says

    The Federal Circuit on Thursday refused to let a law firm off the hook for about $23,000 in sanctions implemented by a federal judge for not complying with a discovery order in a door manufacturing patent case, ruling that the judge did not improperly rely on a letter the firm said he did.

Expert Analysis

  • AI Agents Will Test The Bounds Of Expert Witness Rules

    Author Photo

    Rule 702 of the Federal Rules of Evidence does not address whether a testifying expert must be human, but as the rule’s amended admissibility framework intersects with the accelerating capabilities of agentic AI, courts may be forced to confront whether AI-generated expertise fits within existing evidentiary doctrine, says Steven Cordero at Akerman.

  • Reel Justice: 'Project Hail Mary' Can Aid Cross-Examination

    Author Photo

    In the new science fiction film, "Project Hail Mary," a character understood that survival depended on eliminating ambiguity — a useful lesson that trial lawyers can implement by asking statements that are delivered in the form of a question during cross-examination, says Veronica Finkelstein at Wilmington University.

  • Series

    Judges On AI: How Courts Can Survive The Tech Revolution

    Author Photo

    Colorado Supreme Court Justice Maria Berkenkotter and Colorado Court of Appeals Judge Lino Lipinsky de Orlov discuss how artificial intelligence has already fundamentally altered the legal system and offer tips for courts navigating deepfakes, hallucinations and a gap in access to AI tools.

  • 'Skinny Label' Arguments Spotlight Induced Infringement Risk

    Author Photo

    Recent oral arguments before the U.S. Supreme Court in Hikma Pharmaceuticals v. Amarin Pharma highlight the uncertain boundary between lawful generic competition through so-called skinny labels and induced patent infringement, with potential implications for patent holders’ communication, enforcement and causation strategies across industries, says Anton Hopen at Trenam.

  • What Jury Holdouts Can Teach Trial Lawyers About Strategy

    Author Photo

    Though a hung jury can be a disappointment, a psychological understanding of jury holdouts can help trial lawyers shape their damages arguments and understand leadership and group composition as a function of jury selection, says Clint Townson at Townson Litigation.

  • Model Jury Instructions Provide Next Step In Aligning DTSA

    Author Photo

    As the Defend Trade Secrets Act turns 10, new model jury instructions published by the Sedona Conference map emerging issues and jurisdictional splits, representing a significant step toward harmonizing DTSA trial practice, says Amy Candido at Simpson Thacher.

  • Exploring The Legal Gray Area Around AI Voices In Music

    Author Photo

    The growing prevalence of AI music on online platforms highlights unique legal questions and ambiguities surrounding the usage of artificial intelligence to create accurate voice clones of existing singers, says Michael Maicher at Volpe Koenig.

  • 3 AI Adoption Mistakes GCs Should Avoid

    Author Photo

    The pressure in-house legal teams face to quickly adopt artificial intelligence tools, combined with budget constraints and the need to evaluate a crowded market of options, sets the stage for implementation mistakes that are often difficult to undo, says former 23andMe general counsel Guy Chayoun.

  • Framing AI Risk Management In The Art World

    Author Photo

    With gallery professionals indicating a widening gap between operational adoption of artificial intelligence and cultural acceptance of AI as an art medium, certain intellectual property, privacy and governance considerations are becoming critical for art industry stakeholders, say attorneys at Holland & Knight.

  • Series

    Playing Basketball Makes Me A Better Lawyer

    Author Photo

    My grandfather used to say "I wear your jersey" as shorthand for wholly committing to support someone with loyalty and integrity — ideals that have shaped my life on the basketball court and in legal practice, says Tracy Schimelfenig at Schimelfenig Legal.

  • Salt-N-Pepa Suit May Shake Up Music Copyright Issue

    Author Photo

    James v. UMG Recordings is a copyright termination rights case that provides an opportunity for the Second Circuit to make concrete choices about grant language, authorship, work-for-hire status and survival of derivative works, says attorney Abdul Abdullahi.

  • Series

    The Biz Court Digest: Georgia Court Has Business On Its Mind

    Author Photo

    Thanks to recent legislation, the Georgia State-wide Business Court will soon offer business litigants greater access to the court than ever before, further enhancing the court's emphasis on efficiency, predictability and accessibility for sophisticated commercial disputes, says former GSBC judge Walt Davis at Jones Day.

  • Opinion

    USPTO Must Address The Right Question In Sanofi Case

    Author Photo

    The U.S. Patent and Trademark Office Appeals Review Panel's questions in Ex parte Baurin indicate recognition of broader doctrinal issues, but rather than approaching from separate angles, the panel should concentrate on a single fundamental question about obviousness-type double patenting, says Jeremy Lowe at Spencer Fane.

  • 4 Emerging Approaches To AI Protective Order Language

    Author Photo

    Over the last year, at least five federal district courts have issued or analyzed specific protective order provisions restricting the use of generative artificial intelligence platforms with protected materials, establishing that proactive AI-specific provisions are now standard practice and demonstrating that no single model works for every case, says Joel Bush at Kilpatrick.

  • What Justices Are Focusing On In 'Skinny Label' Patent Case

    Author Photo

    Though Hikma v. Amarin appears to be a patent dispute that could reshape inducement doctrine in the pharmaceutical context, oral argument suggests the U.S. Supreme Court may treat this as primarily a pleading-stage dispute, with important unresolved questions lurking beneath the surface, says Shashank Upadhye at Upadhye Tang.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.